Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50157 | 1.00 | — | — | |
| SCHEMBL3027158 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL1442122 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL5162851 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL3028721 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL25819 | 1.00 | — | — | |
| SCHEMBL130984 | 1.00 | — | — | |
| SCHEMBL5162640 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL3030542 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB | |
| SCHEMBL3029726 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CES2CES1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001092420-A2 | PERYLENE DYES WITH PERSISTENT FLUORESCENCE CAUSED BY STERIC INHIBITION OF AGGREGATION | RADIANT COLOR N.V. (BE) | 2001-12-06 | — | — | WO | claimed |
| EP-0446748-A2 | Use of perylenedyes for the preparation of write, print or copying materials | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1991-09-18 | — | — | EP | claimed |
| EP-1957073-B1 | MEDICINAL DRUG | OTSUKA PHARMA CO LTD (JP) | 2014-04-23 | — | — | EP | disclosed |
| EP-2612858-A1 | STAT3/5 activation inhibitor | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-20120322807-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-12-20 | — | — | US | disclosed |
| US-20120238750-A1 | AROMATIC COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-09-20 | — | — | US | disclosed |
| US-8263599-B2 | STAT3/5 activation inhibitor | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8236826-B2 | Diarylether derivatives as antitumor agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-08-07 | — | — | US | disclosed |
| US-8188277-B2 | Aromatic compounds for suppressing the generation of collagen | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-05-29 | — | — | US | disclosed |
| US-20100210661-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-08-19 | — | — | US | disclosed |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-01-07 | — | — | US | disclosed |
| EP-0896964-A2 | Perylenehydrazideimides as carbonyl derivatizing agents | Ciba SC Holding AG (CH) | 1999-02-17 | — | — | EP | disclosed |
| WO-1998039333-A1 | CROWN ETHER-DERIVATISED PERYLENES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-09-11 | — | — | WO | disclosed |
| WO-1998032799-A1 | BIFLUOROPHORIC PERYLENE COLOURANTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-07-30 | — | — | WO | disclosed |
| WO-1998031678-A1 | PREPARATION OF PERYLENE-3,4-DICARBOXYLIC ANHYDRIDES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-07-23 | — | — | WO | disclosed |
| WO-1997041176-A1 | DONOR-SUBSTITUTED OXINDIGO DERIVATIVES AND THEIR USE AS COLOURANTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1997-11-06 | — | — | WO | disclosed |
| US-5354869-A | Fluorescent dyes | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1994-10-11 | — | — | US | disclosed |
| US-5266700-A | Bipyridyls and their use as inks | RIEDEL-DE-HAEN (DE) | 1993-11-30 | — | — | US | disclosed |
| EP-0446748-A2 | Use of perylenedyes for the preparation of write, print or copying materials | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1991-09-18 | — | — | EP | disclosed |
| WO-1991000276-A1 | BIPYRIDYLES, PROCESS FOR MAKING THEM AND THEIR USE | RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) | 1991-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238750-A1 | AROMATIC COMPOUND | CBR1, CBR3, CYP1A1 | ALDH1A1 565/4885HSD17B10 1452/4885CES2 1392/4885 |
| US-20120322807-A1 | STAT3/5 ACTIVATION INHIBITOR | STAT3, JAK2, STAT1 | ALDH1A1 2295/4885HSD17B10 2339/4885CES2 3184/4885 |
| US-20100210661-A1 | STAT3/5 ACTIVATION INHIBITOR | STAT3, JAK2, STAT1 | ALDH1A1 1814/4885HSD17B10 1922/4885CES2 3247/4885 |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | ROS1, CBR1, CBR3 | ALDH1A1 265/4885HSD17B10 1295/4885CES2 2426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.